Emerging biopharma and top pharma companies alike are looking to virtual sites to expand patient access, deliver greater patient diversity, and reduce clinical trial timelines.
But what does a virtual site really do?
Beyond Decentralized Clinical Trial (DCT) technology, a virtual site enables the operationalization of a remote trial. It incorporates HCPs for procedures, brings mobile nurses to the patient’s home, and delivers flexible study conduct—supporting the patient wherever they are.
In this 30-minute video-on-demand, learn the key factors that must be considered prior to the implementation of a virtual site, and listen to Science 37 experts as they discuss the path forward to deliver patient-friendly clinical trials.
Complete the form to discover the ‘ins and outs’ of the Metasite™.
Shaalan Beg, MD, VP, Oncology, Science 37
Darcy Forman, Chief Delivery Officer, Science 37